IP Verse

Deva Holding competitive analysis

Explore the latest publications and patents granted to Deva Holding, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Deva Holding against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 22, 2025

Discover the latest PTAB cases involving Deva Holding, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Deva Holding with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
DEVA HOLDING	1	-	-	-	Highly Aggressive
NOVARTIS	6	406	-	21	Defensive